Florent Cespedes analyst SOCGEN

Currently out of the existing stock ratings of Florent Cespedes, 1 are a HOLD (25%), 1 are a SELL (25%), 2 are a BUY (50%).

Florent Cespedes

Work Performance Price Targets & Ratings Chart

Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 25% that have a potential upside of 2.92% achieved within 144 days.

Florent Cespedes’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 16-Feb-2023.

Wall Street Analyst Florent Cespedes

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).

Average potential price target upside

LLY Eli Lilly and Company NVS Novartis AG ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$928

$104.38 (12.67%)

$1030

25 days ago
(14-Apr-2025)

16/18 (88.89%)

$173.65 (23.02%)

539

Buy

$1124

$300.38 (36.47%)

$1158

1 months ago
(09-Apr-2025)

29/34 (85.29%)

$370.29 (49.13%)

176

Buy

$1100

$276.38 (33.56%)

$970

2 months 4 days ago
(05-Mar-2025)

13/16 (81.25%)

$170.28 (18.32%)

66

Buy

$1038

$214.38 (26.03%)

$1033

3 months 6 days ago
(03-Feb-2025)

1/4 (25%)

$228.96 (28.30%)

55

Buy

$1190

$366.38 (44.48%)

$1250

3 months 11 days ago
(28-Jan-2025)

0/3 (0%)

$386.39 (48.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Florent Cespedes?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?